Clinical and Prognostic Significance of Ace Gene Polymorphisms in Cerebrovascular Disease

Authors

  • A.A. Yuldashev , D.S. Kushaeva , U.T. Nugmanova , R.R. Talipov , A.А. Pulatov

DOI:

https://doi.org/10.47750/pnr.2022.13.S08.370

Abstract

This article presents the prognostic significance of ACE gene polymorphisms in various degrees of cerebrovascular disease. The main aim of the ACE gene is to encode the angiotensin-converting enzyme, which catalyzes inactive angiotensin I into active angiotensin II. In 2001, the prevalence of brain pathological defects was 247,2 per 100.000 populations in the Republic of Uzbekistan.

Downloads

Published

2022-12-09 — Updated on 2022-12-09

Versions

Issue

Vol. 13 SPECIAL ISSUE 08 (2022)

Section

Articles

How to Cite

Clinical and Prognostic Significance of Ace Gene Polymorphisms in Cerebrovascular Disease. (2022). Journal of Pharmaceutical Negative Results, 2955-2959. https://doi.org/10.47750/pnr.2022.13.S08.370